Sean E. Sissons

Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity

Jeremy R. Graff, Bruce W. Konicek, Thomas M. Vincent et al. · Journal of Clinical Investigation · 2007 · 375 citations · Full text

Tumor Biology, Therapeutic Suppression, Medicine +12

The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

Christopher J. Sweeney, Kathy D. Miller, Sean E. Sissons et al. · PubMed · 2001 · 333 citations

Antiangiogenic Property, Immunology, Docetaxel Treatment +18

A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

Tinggui Yin, Marı́a José Lallena, Emiko L. Kreklau et al. · Molecular Cancer Therapeutics · 2014 · 101 citations · Full text

Tumor Biology, Medicine, Malignant Blood Disorder +14

A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy

Huaxian Chen, Joy L. Kovar, Sean E. Sissons et al. · Analytical Biochemistry · 2004 · 86 citations

Cell-based Immunocytochemical Assay, Immunocytochemical Technique, Signal Transduction +12

Effects of tetracyclines on angiogenesis in vitro

Rose Fife, George W. Sledge, Sean E. Sissons et al. · Cancer Letters · 2000 · 46 citations

Angiogenesis, Medicine, Vascular Biology +3